Keyword Connections

triple-negative

Journals

1

1 breast (edinburgh, scotland)

Research Groups

0

No Research Group Connected

Bibliographies

36

1 Comparison of outcomes between metaplastic and triple-negative breast cancer patients.

2 Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.

3 gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line.

4 Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer

5 BRCA1 promoter methylation in peripheral blood is associated with the risk of triple-negative breast cancer.

6 Multimodal Polysilsesquioxane Nanoparticles for Combinatorial Therapy and Gene Delivery in Triple-Negative Breast Cancer.

7 Role of osteopontin as a predictive biomarker for anti-EGFR therapy in triple-negative breast cancer.

8 CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer.

9 Tryptone-stabilized gold nanoparticles induce unipolar clustering of supernumerary centrosomes and G1 arrest in triple-negative breast cancer cells.

10 Asporin: The protective wall against triple-negative breast cancer

11 Differences in molecular features of triple-negative breast cancers based on the age at diagnosis

12 Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs

13 Structural modifications on CORM-3 lead to enhanced anti-angiogenic properties against triple-negative breast cancer cells.

14 Magnetically Guided Self-Assembled Protein Micelles for Enhanced Delivery of Dasatinib to Human Triple-Negative Breast Cancer Cells.

15 Potentiation of cancerous progression by LISCH7 via direct stimulation of TGFB1 transcription in triple-negative breast cancer.

16 Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.

17 Triple-Negative Lobular Breast Cancer Causing Hydronephrosis.

18 Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion

19 SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer

20 Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer.

21 novel therapeutic strategies for patients with triple-negative breast cancer

22 development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype

23 male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature

24 phenethyl isothiocyanate suppresses stemness in the chemo- and radio-resistant triple-negative breast cancer cell line mda-mb-231/ir via downregulation of metadherin

25 real-time tracking of ex vivo-expanded natural killer cells toward human triple-negative breast cancers

26 caffeic acid phenethyl ester and ethanol extract of propolis induce the complementary cytotoxic effect on triple-negative breast cancer cell lines

27 novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy

28 polysaccharide from sepia esculenta ink and cisplatin inhibit synergistically proliferation and metastasis of triple-negative breast cancer mda-mb-231 cells

29 combined inhibition of atr and wee1 as a novel therapeutic strategy in triple-negative breast cancer

30 biologic roles of estrogen receptor-β and insulin-like growth factor-2 in triple-negative breast cancer

31 yiqi formula enhances the antitumor effects of erlotinib for treatment of triple-negative breast cancer xenografts

32 resistance to taxanes in triple-negative breast cancer associates with the dynamics of a cd49f+ tumor-initiating population

33 cytotoxicity of the urokinase-plasminogen activator inhibitor carbamimidothioic acid (4-boronophenyl) methyl ester hydrobromide (bc-11) on triple-negative mda-mb231 breast cancer cells

34 Palbociclib stimulates CD8+ T cell response in triple-negative breast cancer via regulating phosphoglycerate dehydrogenase.

35 Development of silver-based hybrid nanoparticles loaded with eEF2 K-siRNA and quercetin against triple-negative breast cancer.

36 Berry-derived gold nanoparticles induce integrated ROS-mediated apoptosis, immune modulation, and transcriptomic remodeling in 4T1 triple-negative cancer cells.